Evidence map›Paper›PMID 38665243›Full record

ArticleFrontiers in public health2024

An online survey on public awareness of drug clinical trials in inland cities of northern China.

Li Wang, Ruiguang Zhang, Jingxuan Liu, Rui Xu, Lili Zhao, Enze Li, Yurong Zhang

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li Wang *Department of Scientific Research, Faculty of General Family Medicine, the First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.
Ruiguang Zhang *Xi'an Evidence Based Pharmaceutical Technology Co., Ltd, Xi'an, China.
Jingxuan Liu *Department of Health Statistics, Faculty of Public Health, Shaanxi University of Chinese Medicine, Xi'an, Shannxi, China.
Rui XuDepartment of Scientific Research, Faculty of General Family Medicine, the First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.
Lili ZhaoDepartment of Scientific Research, Faculty of General Family Medicine, the First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.
Enze LiDepartment of Scientific Research, Faculty of General Family Medicine, the First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.
Yurong ZhangDepartment of Scientific Research, Faculty of General Family Medicine, the First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aims of this survey were to investigate the public awareness of drug clinical trials (DCTs) and willingness to participate the DCTs, and provide references for propaganda and science popularization of DCTs. Methods: A self-designed questionnaire named "an online survey questionnaire on public awareness of DCTs" was used to conduct an online survey from January to March 2022. The demographic characteristics and the response of participants to the awareness and willingness to participate the DCTs were collected. The factors affecting the public awareness of DCTs were analyzed by single factor and binary logistic regression analysis. Results: One thousand three hundred eighty valid questionnaires were collected, and the respondents' awareness rate of DCTs was 61.1%. Thirteen demographic characteristics including age, gender, education, occupation, work fields, household type, marital status, city type, income, medical insurance, medical expenditure, pressure to seek medical care, financial pressure, both significantly affected the qualified rate of participants' awareness of DCTs ( Conclusion: The public awareness rate of DCTs and the willingness to participate in drug clinical were significantly affected by the demographic characteristics of subjects. Thus, targeting the needs of the public, propaganda, and science popularization of DCTs should be carried out and served public health.

Indexed as

Clinical Trials as TopicAdolescentAdultAgedAwarenessChinaCitiesFemaleHealth Knowledge, Attitudes, PracticeHumansInternetMaleMiddle AgedSurveys and QuestionnairesYoung Adultawareness of drug clinical trialsdrug clinical trialsin northern Chinapublicwillingness to participate the drug clinical trials

Identifiers

PMID38665243
PMCPMC11043599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.